Title: Borneo Journal of Pharmacy
ISSN: 2621-4814 (Online)
Accreditation: SINTA 2
Subject: Pharmacy
Frequency: Quarterly (4 issues per year in February, May, August, and November) onward February 2020
Indexed at: EMBASE, SINTA 2, Dimensions, DOAJ, SHERPA RoMEO, Crossref, ICI, ResearchBib, Google Scholar, GARUDA, and more
DOI: 10.33084/bjop
Archive preservation: Indonesia OneSearch, GARUDA
Publisher: Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya
Editor in Chief: Mohammad Rizki Fadhil Pratama

Borneo Journal of Pharmacy (Borneo J Pharm, ISSN: 2621-4814 (online)) is an international scientific journal managed by the Department of Pharmacy Faculty of Health Science Universitas Muhammadiyah Palangkaraya and published four times a year (in February, May, August, and November) onward February 2020 by Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya. Borneo Journal of Pharmacy accepts scientific articles in the form of original research articles, short communication, reviews, and mini-reviews from anyone without any discrimination, as long as they submit articles that meet scientific principles. As a distinctive feature, the Borneo Journal of Pharmacy prioritizes research articles conducted on the island of Borneo (consisting of Indonesia, Malaysia, and Brunei Darussalam), as well as those conducted by researchers from institutions on the island of Borneo. In every volume, there are always articles written by authors from the island of Borneo. However, articles from researchers outside the island of Borneo are also welcome.

Borneo Journal of Pharmacy publishes various scientific articles covering Pharmaceutical Sciences, in the field but not limited to Pharmacology-Toxicology, including pharmacokinetics, pharmacodynamics, pharmacotherapy, and toxicology; Pharmacognosy-Phytochemistry, including pharmacognosy, phytochemistry, ethnobotany, and ethnopharmacology; Pharmaceutical, including biopharmaceuticals, pharmaceutical technology, formulations, and biotechnology; Analytical Pharmacy-Medicinal Chemistry, including pharmaceutical chemistry, chemical analysis, medicinal chemistry, bioinformatics, pharmacy physics, pharmaceutical analysis, and method validation; Microbiology Pharmacy, including the test for antibacterial, antifungal and antiviral activity; Natural Product Development, including testing the pharmacological activity of extracts, fractions, and plant isolates; Clinical-Community Pharmacy, including monitoring usage, side effects, counseling, and evaluation of drug use; Management Pharmacy, including drug management, drug use profiles, pharmaceutical administration, and marketing.

Borneo Journal of Pharmacy provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. All articles published in the Borneo Journal of Pharmacy are open access and free for access as stated on Budapest Open Access Initiative:

"By 'open access' to this literature, we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited."

Editors accept submissions of the well-prepared manuscript that has not been published in other publications. The manuscript format and requirements are listed on the back cover page. Incoming manuscripts will be evaluated and edited to uniformity of structures, terms, and other writing procedures. All manuscripts will be reviewed by the double-blind method by our selective reviewer.

It was first published in 2018 using the Open Journal System (OJS) 3.1. Every year, the Borneo Journal of Pharmacy publishes between 24 and 42 articles divided into four issues. Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions. 

Borneo Journal of Pharmacy is accredited at "SINTA 2" until February 2025 by the Minister of Research and Technology/National Research and Innovation Agency, Indonesia No: 148/M/KPT/2020.

Announcements

Notification of limitations on publishing review articles and articles using the molecular docking method

2022-04-24

Dear prospective authors from the Borneo Journal of Pharmacy,

Due to the large number of submissions we receive, while our review and editing capacity is limited (only publishing 40 articles a year), we are forced to implement several policies regarding the restrictions on the types of articles that can be processed in the Borneo Journal of Pharmacy. These restrictions apply to:

1. Review Articles
We currently process many review articles, both narrative and systematic reviews (nearly 30% of the number of manuscripts processed). We apply a limit on the number of review articles in each issue of no more than 30% to accommodate original research articles, so we must limit the number of review articles that we can process. This limitation does not apply to manuscripts sent based on invitations to potential authors.

2. Articles with Molecular Docking Method
Currently, the Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya publishes a journal that explicitly publishes various articles using the molecular docking method as the primary method: Journal of Molecular Docking (http://journal.umpalangkaraya.ac.id/index.php/jmd). Considering the high traffic of articles in the Borneo Journal of Pharmacy, including those that publish articles on molecular docking, we are temporarily not accepting articles of this type. We will advise authors to move their submissions to the Journal of Molecular Docking. This limitation does not apply to manuscripts that use molecular docking as a complementary method and not the primary analysis method.

The restrictions on these two types of manuscripts will be in place for 2022 and re-evaluated at the end of 2022. Once again, we thank all authors and prospective authors from the Borneo Journal of Pharmacy.
Regards,
Editor-in-Chief
Borneo Journal of Pharmacy

Read more about Notification of limitations on publishing review articles and articles using the molecular docking method

Current Issue

Vol 5 No 2 (2022): Borneo Journal of Pharmacy

The publication of the Borneo Journal of Pharmacy positively participates in disseminating research and review of science and technology development conducted by lecturers and researchers, primarily from Universitas Muhammadiyah Palangkaraya and other universities. This edition includes writings from four countries: India, Indonesia, Nigeria, and Sri Lanka. The authors come from several institutions, including Universitas Pancasila, University of Jaffna, Universitas Muhammadiyah Prof. Dr. HAMKA, Universitas Setia Budi, Federal University Birnin Kebbi, Kano State Polytechnic, Universitas Muhammadiyah Palangkaraya, Prathima Institute of Medical Sciences, Bhaskar Pharmacy College, Ganapathy Degree College, Universitas Muhammadiyah Malang, Universitas Muhammadiyah Magelang, and Universitas Andalas.

DOI: https://doi.org/10.33084/bjop.v5i2
Published: 2022-05-31

Editorial Notes

Pharmacology-Toxicology

Pharmacognosy-Phytochemistry

Pharmaceutical

Microbiology Pharmacy

Natural Product Development

Clinical-Community Pharmacy

View All Issues